Second Annual Medical College of Wisconsin Advances in Musculoskeletal Oncology and Sarcoma Symposium

Green Bay, WI US
September 8, 2017

Musculoskeletal Oncology is constantly evolving with a variety of treatment techniques applicable to many subspecialties.  Providers, while focusing on their specialty, must be aware of new and evolving technologies and treatment techniques in subspecialties other than their own. This conference is intended to enhance the overall fund of knowledge required for these providers to inform their colleagues and patients on alternative treatment options that may be available.

 

ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement:
The Medical College of Wisconsin designates this Live Activity for a maximum of 4.75 AMA PRA Category 1 Credit(s) ™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Hours of Participation for Allied Health Care Professionals:
The Medical College of Wisconsin designates this activity for up to 4.75 hours of participation for continuing education for allied health professionals. 

 

*Please note:  Google Chrome and Mozilla Firefox are the preferred browsers. 

*For more information:  [email protected]
 
*Lambeau Field Tours Available!

Stadium tours of Lambeau Field are available.  Go to http://www.packers.com/lambeau-field/stadium-tours.html for more information.

 

 

Target Audience

This symposium is designed to provide updates on the advancements in treating musculoskeletal oncologic disorders to improve knowledge and skills in caring for patients. The intended audience incudes:

  • Orthopaedic and General Surgeons
  • Radiation Oncologists
  • Medical Oncologists
  • Radiologists and Interventional Radiologists
  • Physician Assistants
  • Nurse Practitioners

Learning Objectives

At the conclusion of this activity, I will be able to:

  1. Recognize and understand the importance of a multidisciplinary approach to the care of musculoskeletal oncology patients
  2. Provide updates on the current clinical practice in musculoskeletal oncology
  3. Provide updates on clinical trials in musculoskeletal oncology
  4. Acquire an awareness and understanding of minimally invasive options for patients with metastatic bone disease
  5. Assess emerging data and technical information regarding changes and progress in the management of major forms of musculoskeletal oncology
  6. Assess the significance of new musculoskeletal oncology approaches and technologies for the treatment of various patients
  7. Provide updates on clinical trials in musculoskeletal oncology/novel agents in sarcoma
  8. Acquire an awareness and understanding of minimally invasive options for patients with metastatic bone disease
Additional information

Contact

Name: 
Jessica Kotowicz
Phone Number: 
+1 (414) 805-4505
Email: 
[email protected]
Course summary
Available credit: 
  • 4.75 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 4.75 Hours of Participation
    Hours of Participation credit.
Course opens: 
07/20/2017
Course expires: 
02/28/2018
Event starts: 
09/08/2017 - 8:00am CDT
Event ends: 
09/08/2017 - 3:00pm CDT
Cost:
$0.00
Add to calendar: 

This day-long educational symposium is designed to provide updates on the advancements in treating musculoskeletal oncologic disorders. The intended audience is practicing general and orthopaedic surgeons, radiation and medical oncologists, surgical oncologists, radiologists, mid-level providers and residents who would like to improve their knowledge and skills in caring for patients with musculoskeletal oncology issues. The symposium will include lectures, expert panel discussions, and case based discussions. Learners will have an opportunity to interact with faculty and ask questions relevant to their own practice and learning.

Lambeau Field Stadium
1265 Lombardi Avenue
Green Bay, WI 54304
United States
Planning Committee:
Meena Bedi, MD, Assistant Professor, Radiation Oncology, Medical College of Wisconsin
David M. King, MD, Professor and Chairman, Orthopaedic Surgery, Medical College of Wisconsin
John A. Charlson, MD, Associate Professor, Hematology Oncology, Medical College of Wisconsin
Lori Hollingsworth-Burds, PA-C, Orthopaedic Surgery, Medical College of Wisconsin
Julie Waugh, NP, Hematology Oncology, Medical College of Wisconsin

 

 

Presenters:
Andrew Wagner, MD, PhD, Assistant Professor, Hematology Oncology, Dana Farber Cancer Institute
Vinai Gondi, MD, Director of Research, Northwestern Medicine Chicago Proton Center
Meena Bedi, MD, Assistant Professor, Radiation Oncology, Medical College of Wisconsin
Callisia Clarke, MD, Assistant Professor, Surgical Oncology, Medical College of Wisconsin
David M. King, MD, Professor and Chairman, Orthopaedic Surgery, Medical College of Wisconsin
John C. Neilson, MD, Assistant Professor, Orthpaedic Surgery, Medical College of Wisconsin
 

 

 

All person in control of content have NO relavant financial relationships to disclose

NameCompanyRole
Vinai Gondi, MDInsys Biotherapeutics
Novocure		Advisory Board
Educational Speaker
John Neilson, MDMusculoskeletal Transplant FoundationBoard Member
Andrew J. Wagner, MD, PhDEli Lilly
Five Prime Therapeutics		Advisory Board
Advisory Board

In accordance with the ACCME®  Standards for Commercial Support Number 6, all in control of content disclosed any relevant financial relationships. These relationships were reviewed via the MCW conflict of interest resolution process and resolved

 

Available Credit

  • 4.75 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 4.75 Hours of Participation
    Hours of Participation credit.

Price

Cost:
$0.00
Please login or register to take this course.